PHILADELPHIA TRUST CO - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 76 filers reported holding HUMACYTE INC in Q4 2022. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
PHILADELPHIA TRUST CO ownership history of HUMACYTE INC
ValueSharesWeighting
Q2 2024$48
+54.8%
10,0000.0%0.00%
+100.0%
Q1 2024$31
+10.7%
10,0000.0%0.00%
-33.3%
Q4 2023$28
-3.4%
10,0000.0%0.00%0.0%
Q3 2023$290.0%10,0000.0%0.00%0.0%
Q2 2023$29
-6.5%
10,0000.0%0.00%0.0%
Q1 2023$31
+47.6%
10,0000.0%0.00%
+50.0%
Q4 2022$21
-99.9%
10,0000.0%0.00%
-50.0%
Q3 2022$33,000
+3.1%
10,0000.0%0.00%
+33.3%
Q2 2022$32,000
-54.9%
10,0000.0%0.00%
-50.0%
Q1 2022$71,000
-2.7%
10,0000.0%0.01%
+20.0%
Q4 2021$73,000
-58.0%
10,000
-33.3%
0.01%
-61.5%
Q3 2021$174,00015,0000.01%
Other shareholders
HUMACYTE INC shareholders Q4 2022
NameSharesValueWeighting ↓
Endowment Wealth Management, Inc. 100,518$482,4860.35%
Monashee Investment Management LLC 280,000$1,344,0000.17%
United Asset Strategies, Inc. 218,308$1,047,8780.10%
HAMILTON LANE ADVISORS LLC 21,893$105,0860.08%
GSA CAPITAL PARTNERS LLP 224,179$1,0760.08%
David J Yvars Group 22,750$109,2000.07%
ARS Investment Partners, LLC 116,419$558,8110.05%
EntryPoint Capital, LLC 5,180$24,8640.04%
Virtu Financial LLC 103,163$4950.04%
Anson Funds Management LP 50,000$240,0000.03%
View complete list of HUMACYTE INC shareholders